Laboratorium fistulae

Productum

Pimobendan 74150-27-9 Metabolismus PDE inhibitor

Description:

Product nomen:Pimobendan
Synonyma:4,5-Dihydro-6-[2-(4-methoxyphenyl)-1H-benzimidazol-6-yl]-5-methyl-3(2H)-pyridazinone
CAS No.:74150-27-9
Qualitas:USP43
Formulae hypotheticae:C19H18N4O2
Pondus hypotheticum:334.37


Product Detail

Product Tags

Mercedem:T/T, L/C
Product Origin:China
Shipping Portus:Beijing/Shanghai/Hangzhou
Order (MOQ);1g
Tempus ducere:III opus diebus
Facultas productio;1kg / mensis
Repono conditione:Condita in loco frigido, sicco, cella temperie.
Sarcina materia:phialam, lagenam
Sarcina amplitudo:1g/ phialam, 5/ phialam, 10g/ phialam, 50g/ utrem, 500g/ utrem
Salus notitia:UN 2811 6.1/PG 3

Pimobendan

Introductio

Pimobendan, medicamentum VETERINARIUS.Calcium sensitivum est et inhibitor selectivorum phosphodiesteraseos 3 (PDE3) cum effectibus inotropicis et vasodilatoris positivis.

Pimobendan in administratione cordis defectionis in canibus adhibetur, maxime causata ex valvae myxomatous mitrali morbo (etiam antea endocardiosis), vel cardiomyopathy dilatato.Investigatio demonstravit pimobendan ut monotherapia superesset tempus augere et meliorem qualitatem vitae in aegros caninis cum corde congestivo defectum secundae ad morbum valvae mitralis comparatum cum benazepril, inhibitore ACE.

Specification (USP43)

Item

Specification

Aspectus

Pulvis albidus vel subluteus, hygroscopic

Mp

About 242℃

Solubilitas

In aqua fere solubilis, libere solubilis in dimethylformaide, leviter solubilis in acetoneo et in methanilia.

Lepidium sativum

Effusio spectrophotometriae infrared, Comparatio pimobendan CRS.

Retentionis tempus solutionis maioris cacuminis sample solutionis respondet solutioni stirpis Standardi, prout in Impuritatibus organicis habetur.

Metalla gravis

≤10ppm

Granularity

P90 ≤ 25μ m

Magnitudo particula

20-80 reticulum

RELICTUM menstrua

≤ 500ppm

Aquae

≤ 1.0%

Assay

98.0%~ 102.0%

Cinis sulphated

≤ 0.10%

Substantiae cognatae (HPLC)

immunditiam A

≤ 0.10%

immunditiam B *

≤ 0.10%

Alia immunditia

≤ 0.10%

Totalis immunditiae

≤ 0.20%


  • Previous:
  • Deinde: